XORTX Therapeutics Inc.
XRTX
$2.28
-$0.03-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.74M | -2.77M | -2.66M | -1.94M | -1.88M |
| Total Depreciation and Amortization | 102.60K | 111.90K | 112.10K | 109.10K | 105.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -143.40K | -328.90K | -560.80K | -1.24M | -1.42M |
| Change in Net Operating Assets | -1.32M | 356.70K | 336.20K | 116.50K | 117.20K |
| Cash from Operations | -5.10M | -2.63M | -2.77M | -2.95M | -3.08M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -417.20K | -299.50K | -295.00K | -34.70K | -52.40K |
| Cash from Investing | -417.20K | -299.50K | -295.00K | -34.70K | -52.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -80.50K | -88.70K | -89.60K | -90.50K | -91.30K |
| Issuance of Common Stock | 7.14M | 2.14M | 2.26M | 2.65M | 1.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.61M | -797.60K | -738.40K | -660.50K | -413.30K |
| Cash from Financing | 5.46M | 1.26M | 1.43M | 1.90M | 1.11M |
| Foreign Exchange rate Adjustments | -8.30K | 25.10K | 27.00K | -20.90K | 3.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.40K | -1.65M | -1.61M | -1.11M | -2.02M |